MedPath

Uterine Lesions and Their Association to Invitro Fertilization(IVF) or Intracytoplasmic Sperm Injection(ICSI) Outcome

Conditions
IVF
Interventions
Procedure: IVF
Registration Number
NCT04939376
Lead Sponsor
Assiut University
Brief Summary

1. To study the effect of uterine wall , intracavitary , cervical as well as cervical canal lesion on the outcome of IVF/ICSI cycle.

2. To establish a score for prediction of IVF/ICSI cycle success .

Detailed Description

IVF is one of the most successful treatment of fertility, (1) however, several IVF cycles fail to achieve pregnancy (2).failure defined as three or more failed attempts of ICSI (3). Implantation failure is a complex in nature, may be due to structural or functional causes (3, 4).

that previously undiagnosed, misinterpreted initial diagnoses, or subtle newly added intrauterine abnormalities may be a significant cause of IVF failure (5, 6), studies say that intra-uterine pathologies represent 40-50 % of causes of ICSI failure (7, 8), hysteroscopic removal of endometrial polyps, submucous fibroids, uterine septum, or intrauterine adhesions could increase the pregnancy rate (9). so, Evaluation of the uterine cavity may become a routine investigation before assisted reproductive technology(ART) procedures (10).

In this study, we evaluate the relationship between the different uterine and cervical pathologies and decreased live birth rate.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
122
Inclusion Criteria
  • Women between 18 and 38 years old.

    • An indication for IVF/ICSI..
    • Women with BMI between 18.5 : 29.9 .
    • Women with normal antimullerian hormone(AMH), antral follicle count(AFC) (good responders).
Exclusion Criteria

Refusal to join the study.

  • Women with age less than 18 and more than 38 .
  • Women with BMI less than 18.5 and more than 30 .
  • Untreated tubal hydrosalpinges.
  • Poor responders as assessed by AFC 4 or less ,AMH O.8 ng/dl (nice 2013).

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Group BIVFMatched women (eg. Age,parity, BMI, ovarian reserve....) with no uterine or ovarian abnormalities assessed by hysteroscopy or ultrasonography.
Group AIVFWomen with hysteroscopically or ultrasonographic detected uterine anomalies(adenomyosis,fibroid) intracavitary lesions ( like polyp, adhesion or septum) and those with detected endometrial abnormalities (like hypervascularization,pale endometrium) ,cervical lesion and cervical canal lesion or pelvic lesion
Primary Outcome Measures
NameTimeMethod
Pregnancy rateBaseline

Pregnancy rate with IVF/ICSI with uterine lesions

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath